Ep114: Chris Gibson on Industrializing Drug Discovery

1

Introduction

00:00 • 4min

2

The Long Run - Chris Gibson

03:33 • 2min

3

Macursh - What's Your Story?

05:23 • 2min

4

What Kind of School Did You Go To?

07:03 • 2min

5

How Did You Get Interested in Science or Biology?

08:45 • 2min

6

What Was It About Biology That Captured Your Interest?

10:30 • 2min

7

How Did You End Up at the University of Texas, Austin?

12:35 • 3min

8

The University of Texas, a Great Place to Pursue Your Own Thing

15:11 • 4min

9

The Problem With Penotipic Screens in Pathology

19:36 • 3min

10

How Did You Get the Funding?

22:24 • 4min

11

Were You Naive in Those Early Days?

26:40 • 3min

12

The Future of Computational Chemistry

29:34 • 3min

13

Accelerate Drug Development With Ai Powered Three D

32:08 • 4min

14

How Did Genante's Series a Change the Company?

35:54 • 2min

15

The Industrial Revolution of Drug Discovery

38:17 • 3min

16

Creating a Virtuous Cycle of Learning and Iteration

41:30 • 3min

17

Machine Learning Is Changing the Way We Do Business

44:59 • 2min

18

Pivotal Partnerships in Fibrosis

46:37 • 2min

19

Is Fibrosis a Good Place for Imaging?

48:23 • 3min

20

The Partnership With Russia's Genent on Cancer

51:18 • 2min

21

The Currency of Our Industry Is Not Algarisms

53:43 • 2min

22

What's the Difference Between Function First and Project First?

55:30 • 2min

23

The Challenges of Operating in Salt Lake City?

57:52 • 3min

24

Why Did You Open New Offices in Toronto, Montreal?

01:01:08 • 2min

25

Is There a Right or Wrong Shareholder Perspective?

01:02:52 • 4min